- This event has passed.
Welcome to the Flemingsberg ATMP network meeting
October 15 @ 11:30 - 13:00
Our speakers have dealt with some of the challenges in moving their ATMP research into GMP and preparing for a clinical study.
The talks are selected based on the issues brought up by the network members in response to the survey sent out after our last meeting (agenda is attached).
We have a lot to learn from each other´s experiences and we hope that this event will provide inspiration and some new tools for your future work!
We look forward to meeting you on October 15. Lunch sandwiches will be served at 11.30 and the speakers will start at 12.00 and end at 13.05. The meeting is held at Novum, room to be announced.
RSVP to firstname.lastname@example.org. Please respond no later than October 11 so that we can order enough sandwiches.
11.30 – 12.00: lunch wrap and coffee (optional)
Short introduction and welcome: Lilian Walther Jallow, CLINTEC
12.1-12.5 Overview CAMP/SweLife -ATMP
Kristina Kannisto, KCC
12.05-12.15 The new NK-cell competence center
Evren Alici, MedH
12.15-12.30 Vecura; what services do we provide and what is expected of you as a customer
Ulrica Eistrand, Vecura
12.30-12.45 To prepare for a clinical trial; issues and solutions
Cecilia Götherström, Clintec
12.45-13.00 iPSC project; development of a non-traceable cell line
Anna Falk, Dept of Neuroscience
13.00-13.05 Helpful resources; Guides and templates on SweLife-ATMP home page
Marie Westman, KTA
The aim of the Flemingsberg ATMP network is to facilitate clinical research on cell and gene therapies by bringing people together and sharing our knowledge.
The room is available until 2 pm for those who want to stay behind and continue discussions.
The aim of the Flemingsberg ATMP network (supported by a CIMED grant) is to connect available resources with researchers and clinicians and to share our collected knowledge and experience, with the aim of facilitating clinical translation and research. Let´s help each other bring more innovative cell- and gene therapies to patients! Our hope is that this network will assist in spreading information that will make the process of ATMP development from research to patient delivery more effective and to also act as a forum for discussion and assistance in development of practical solutions. Organizers of the network are: Kristina Kannisto, Lilian Walther Jallow and Heather Main.